Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia

Yueren Zhao1 Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan;2 Department of Psychiatry, Okehazama Hospital Fujita Kokoro Care Center, Toyoake, Aichi, Japan;3 Department of Neuropsychiatry, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Kumamoto, JapanCorrespondence[email protected]

Taro Kishi1 Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Nakao Iwata1 Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Manabu Ikeda3 Department of Neuropsychiatry, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Kumamoto, Japan;4 Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Kumamoto, Japan

Pages 1655-1659 | Published online: 29 Oct 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

ConleyRRKellyDLManagement of treatment resistance in schizophreniaBiol Psychiatry20015089891111743944
PubMed Web of Science ®Google Scholar
KishimotoTRobenzadehALeuchtCLong-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trialsSchizophr Bull122013 [Epub ahead of print.]
Web of Science ®Google Scholar
ZhaoYIwataNMulti-centered research of the effectiveness of combined therapies for people with schizophrenia – a Comprehensive Psycho-educational Approach and Scheme Set (COMPASS) while using risperidone long-acting injection therapyPresented at the 3rd Biennial Schizophrenia International Research ConferenceFlorence, ItalyApril 14–18, 2012
Google Scholar
InagakiAInadaTDose equivalence of psychotropic drugs. Part XXII: dose equivalence of depot antipsychotics III: risperidone long-acting injectionJpn J Clin Psychopharmacol20101313491353
Google Scholar
OverallJEGorhamDRThe Brief Psychiatric Rating ScalePsychol Rep196210799812
Web of Science ®Google Scholar
ChaichanWOlanzapine plus fluvoxamine and olanzapine alone for the treatment of an acute exacerbation of schizophreniaPsychiatry Clin Neurosci20045836436815298648
PubMed Web of Science ®Google Scholar
HallRCGlobal assessment of functioning. A modified scalePsychosomatics1995362672757638314
PubMed Web of Science ®Google Scholar
InadaTYagiGMiuraSExtrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidolSchizophr Res20025722723812223254
PubMed Web of Science ®Google Scholar
BirchwoodMToddPJacksonCEarly intervention in psychosis. The critical period hypothesisBr J Psychiatry Suppl199817253599764127
PubMedGoogle Scholar
KamijimaKIshigookaJYKComparison study between risperidone long-acting injectable and risperidone tablets in patients with schizophreniaJpn J Clin Psychopharmacol20091211991222
Google Scholar
RobinsonDWoernerMGAlvirJMPredictors of relapse following response from a first episode of schizophrenia or schizoaffective disorderArch Gen Psychiatry19995624124710078501
PubMed Web of Science ®Google Scholar
TiihonenJHaukkaJTaylorMHaddadPMPatelMXKorhonenPA nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophreniaAm J Psychiatry201116860360921362741
PubMed Web of Science ®Google Scholar
AgugliaEPascolo-FabriciEBertossiFBassiMPsychoeducational intervention and prevention of relapse among schizophrenic disorders in the Italian community psychiatric networkClin Pract Epidemiol Ment Health20073717593299
PubMedGoogle Scholar
AgiusMGohCUlhaqSMcGorryPThe staging model in schizophrenia, and its clinical implicationsPsychiatr Danub20102221122020562749
PubMed Web of Science ®Google Scholar
ChanSWYipBTsoSChengBSTamWEvaluation of a psychoeducation program for Chinese clients with schizophrenia and their family caregiversPatient Educ Couns200975677618963721
PubMed Web of Science ®Google Scholar
Pitschel-WalzGBaumlJBenderWEngelRRWagnerMKisslingWPsychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project StudyJ Clin Psychiatry20066744345216649832
PubMed Web of Science ®Google Scholar
ChabannesJPBazinNLeguayDTwo-year study of relapse prevention by a new education program in schizophrenic patients treated with the same antipsychotic drugEur Psychiatry20082381317964764
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date